Brussels: The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters. The bloc has agreed to pay 15.50 euros ($18.34) per dose for the Covid-19 vaccine candidate being developed by Pfizer and BioNTech, according to the official. That would mean an overall price of up to 3.1 billion euros ($3.7 billion) for 200 million doses, rising to 4.65 billion euros if another optional 100 million doses are purchased under the deal, the official said....Full Article
EU could pay over $10 billion for Pfizer and CureVac vaccines
WorldNews0 shares 1 views
Related news coverage
Biotech company fighting coronavirus shoots down the idea of reportedly giving US exclusive rights to vaccine
· CureVac, a biopharmaceutical based in Germany reportedly rejected a proposal by the US to purchase the exclusive rights to a..
You might like
Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry
· Business Insider has selected the 30 leaders under 40 who are working to transform US healthcare.
· The list includes..